MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
230 hedge funds and large institutions have $3.95B invested in Mirati Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 110 increasing their positions, 60 reducing their positions, and 54 closing their positions.
Holders
230
Holders Change
-22
Holders Change %
-8.73%
% of All Funds
3.89%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.22%
New
36
Increased
110
Reduced
60
Closed
54
Calls
$95.4M
Puts
$24M
Net Calls
+$71.4M
Net Calls Change
+$46.1M
Top Buyers
1 |
1
Goldman Sachs
New York
|
$164M |
2 |
2
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$57.2M |
3 |
3
Morgan Stanley
New York
|
$60.8M |
4 |
4
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
$56.5M |
5 |
PBA
5
Paradigm Biocapital Advisors
New York
|
$44.3M |